CMS approves 'Netflix' model for hepatitis C drugs in Louisiana's Medicaid program

Dollar bill with a hole in Washington's face on it and the word "Medicaid" in its place
Louisiana will be the fifth state to test a subscription model for hepatitis C drugs. (zimmytws/GettyImages)

The Centers for Medicare & Medicaid Services has signed off on Louisiana's plan to use a Netflix-style subscription model to pay for hepatitis C drugs in its Medicaid program. 

CMS announced Wednesday it approved a state plan amendment that would allow Louisiana Medicaid to pay a lump sum to drug manufacturers for antiviral hepatitis C medications for an unlimited supply of the drugs. 

Louisiana is the fifth state to try out this payment arrangement. CMS approved a similar request in Washington earlier this month and had previously given the OK for demonstrations in Oklahoma, Colorado and Michigan. 

Whitepaper

Elevate Health Plan Member Engagement Through Call Center Transformation

Learn how health plans can rapidly transform their call center operations and provide high-touch, concierge service to health plan members.

“The high cost of prescription drugs is one of the greatest challenges in our healthcare system, and Louisiana’s innovative approach to leveraging a subscription model to promote access to hepatitis C therapy is a great example of how states can lead in designing solutions,” CMS Administrator Seema Verma said in a statement. 

RELATED: CMS gives the OK to Maryland Medicaid waiver, allowing diabetes management, dental care demonstrations 

Supplemental rebate arrangements like the one approved in Louisiana are exempt from Medicaid’s “best price” rules. CMS welcomes similar proposals, the agency said. 

Allowing for these alternative payment arrangements is part of CMS’ broader goal of allowing states greater flexibility to shape their Medicaid programs, Verma said. 

“States are best positioned to meet the needs of their Medicaid beneficiaries, and CMS is committed to giving them flexibility to confront the challenges they face,” she said. 

CMS’ efforts in this area have not been without controversy. It has approved demonstrations for work requirements in several states, which have faced legal challenges—a federal judge rejected them in Kentucky and Arkansas earlier this year. 

Suggested Articles

Nearly 10,000 patients involved in research studies were impacted by a third-party privacy breach that may have exposed their medical diagnoses, test results…

Employers looking to continue investing in their wellness programs are eyeing services targeting mental health and women’s health, a new survey shows.

Payers have made strides digitizing and automating many core processes, yet prior authorization remains a largely manual, cumbersome process.